Meet Alessandro Venturino, Co-founder and Head of Research
Alessandro Venturino Co-founder and Head of Research At Syntropic, he spearheads research advancements, drawing on his extensive experience in Neurophysiology. He studied Biomedicine at the…
Filter by quarter:
Microglia enable mature perineuronal nets disassembly upon anesthetic ketamine exposure or 60-Hz light entrainment in the healthy brain
Article Link
Syntropic Medical Awarded EUR 1.1M FFG Grant
Syntropic Medical Secures €1.1M FFG Grant and Multi-Million Investment to Advance Light-Based Therapy for Depression Klosterneuburg, Austria – July 22, 2024 – We at Syntropic…
Creative Destruction Lab Graduation
Creative Destruction Lab 2024 Graduation Berlin Berlin, Germany — July 18, 2024 Syntropic has graduated from the highly competitive Creative Destruction Lab Berlin Health program…
Syntropic Medical Raises 7-Figure Seed Investment from xista science ventures and AWS
Syntropic Medical Raises 7-Figure Seed Investment from xista science ventures and aws to Advance Light-Based Therapy for Mental Health Disorders Vienna, Austria – April 4,…